Speaker's profile
Jose Jimeno
Novita PharmaceuticalsBIOGRAPHY
Jose Jimeno is the medical oncologist at Novita Pharmaceuticals, with extensive experience in oncology drug development and clinical trials. His contributions to Yondelis, now approved in over 60 countries, exemplify a career dedicated to advancing cancer treatments from early research to regulatory approval.
Jose developed Plitidepsin from preclinical to pivotal trials in a myeloma indication, alongside contributions to Epirubicin in breast cancer, Amifostine as a cytoprotector, and Trimetrexate in Pneumocystis carinii pneumonia. His research output includes over 140 peer-reviewed publications on cancer.
become a speaker & join the conversation
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.